Testosterone suppression in the treatment of recurrent or metastatic prostate cancer — A Canadian consensus statement

Testosterone suppression, achieved through orchiectomy or medically induced androgen-deprivation therapy (ADT), is a standard treatment for men with recurrent and metastatic prostate cancer. Current assay methods demonstrate the capacity for testosterone suppression to <0.7 nmol/l, and clinical d...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Can Urol Assoc J
Hlavní autoři: Klotz, Laurence, Shayegan, Bobby, Guillemette, Chantal, Collins, Loretta L., Gotto, Geoffrey, Guérette, Dominique, Jammal, Marie-Paule, Pickles, Tom, Richard, Patrick O., Saad, Fred
Médium: Artigo
Jazyk:Inglês
Vydáno: Canadian Medical Association 2018
Témata:
Consensus Statement
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5937399/
https://ncbi.nlm.nih.gov/pubmed/29680011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.5116
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky